Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy
Dienogest and gonadotropin-releasing hormone agonist with hormone add-back therapy seem to be equally effective for long-term treatment of pain symptoms associated with endometriosis.
Volume 107, Issue 3, Pages 537–548
Authors:
Mohamed A. Bedaiwy, M.D., Ph.D., Catherine Allaire, M.D., Sukinah Alfaraj, M.D.
Abstract:
Endometriosis can recur after either surgical or medical therapy. Long-term medical therapy is implemented to treat symptoms or prevent recurrence. Dienogest and gonadotropin-releasing hormone (GnRH) analogues with hormone add-back therapy seem to be equally effective for long-term treatment of pain symptoms associated with endometriosis. There is insufficient evidence to support the superiority of one therapy over the other. However, add-back hormone therapy (HT) is recommended for patients using GnRH agonists. The treatment selection depends on therapeutic effectiveness, tolerability, drug cost, the physician's experience, and expected patient compliance.
